Crystalline forms of bosentan
US8530488B2 · kind B2 · utility
0Cited by
5References
28Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 24, 2008 |
| Grant date | Sep 10, 2013 |
| Priority date | — |
| Expiry date | Dec 17, 2028 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P11/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to novel crystalline forms of bosentan and processes for their preparation. Further, the invention relates to pharmaceutical compositions comprising said crystalline forms and use of said compositions in the treatment of patients suffering from endothelin receptor mediated disorders, for example, cardiovascular disorders such as hypertension, pulmonary hypertension, ischemia, vasospasm and angina pectoris.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.